Maxim Group Upgrades Co-Diagnostics (CODX) to Buy
Maxim Group analyst Jason McCarthy upgraded Co-Diagnostics (NASDAQ: CODX) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
